FDA Covid-19 Response At a Glance Summary as of September 4, 2020

FDA Covid-19 Response At a Glance Summary as of September 4, 2020

Coronavirus (COVID-19) Update: Daily Roundup September 4, 2020

The U.S. Food and Drug Administration (FDA) today continued to take action in the ongoing response to the COVID-19 pandemic: The FDA issued an updated FDA COVID-19 Response At-A-Glance Summary that provides a quick look at facts, figures, and highlights of the agency's response efforts. Testing updates: To date, the FDA has currently authorized 242 tests under EUAs; these include 194 molecular tests, 44 antibody tests, and 4 antigen tests.